{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:21:54Z","timestamp":1784308914019,"version":"3.55.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T00:00:00Z","timestamp":1685318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T00:00:00Z","timestamp":1685318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Medical University -Sofia","award":["GRANT 2021, D120\/04.06.2021"],"award-info":[{"award-number":["GRANT 2021, D120\/04.06.2021"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-023-03404-9","type":"journal-article","created":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T19:01:40Z","timestamp":1685386900000},"page":"602-612","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Plasma-free metanephrines, nerve growth factor, and renalase significance in patients with PCOS"],"prefix":"10.1007","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4007-9713","authenticated-orcid":false,"given":"Ralitsa","family":"Robeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atanaska","family":"Elenkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgi","family":"Kirilov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Zacharieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,29]]},"reference":[{"key":"3404_CR1","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1016\/j.fertnstert.2010.09.032","volume":"95","author":"R Azziz","year":"2011","unstructured":"R. Azziz, D.A. Dumesic, M.O. Goodarzi, Polycystic ovary syndrome: an ancient disorder? Fertil. Steril. 95, 1544\u20131548 (2011)","journal-title":"Fertil. Steril."},{"key":"3404_CR2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","volume":"29","author":"I Stein","year":"1935","unstructured":"I. Stein, M. Leventhal, Amenorrhea associated with bilateral polycystic ovaries. Am. J. Obstet. Gynecol. 29, 181\u2013191 (1935)","journal-title":"Am. J. Obstet. Gynecol."},{"key":"3404_CR3","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrendo.2018.24","volume":"14","author":"HF Escobar-Morreale","year":"2018","unstructured":"H.F. Escobar-Morreale, Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat. Rev. Endocrinol. 14, 270\u2013284 (2018)","journal-title":"Nat. Rev. Endocrinol."},{"key":"3404_CR4","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/humrep\/dey256","volume":"33","author":"HJ Teede","year":"2018","unstructured":"H.J. Teede, M.L. Misso, M.F. Costello, A. Dokras, J. Laven, L. Moran, T. Piltonen, R.J. Norman, Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum. Reprod. 33, 1602\u20131618 (2018)","journal-title":"Hum. Reprod."},{"key":"3404_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril. 81, 19\u201325 (2004)","journal-title":"Fertil. Steril."},{"key":"3404_CR6","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1210\/clinem\/dgab232","volume":"106","author":"BH Al Wattar","year":"2021","unstructured":"B.H. Al Wattar, M. Fisher, L. Bevington, V. Talaulikar, M. Davies, G. Conway, E. Yasmin, Clinical practice guidelines on the diagnosis and management of polycystic ovary syndrome: a systematic review and quality assessment study. J. Clin. Endocrinol. Metab. 106, 2436\u20132446 (2021)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3404_CR7","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1210\/er.2015-1104","volume":"37","author":"RL Rosenfield","year":"2016","unstructured":"R.L. Rosenfield, D.A. Ehrmann, The Pathogenesis of Polycystic Ovary Syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr. Rev. 37, 467\u2013520 (2016)","journal-title":"Endocr. Rev."},{"key":"3404_CR8","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/rmb2.12262","volume":"18","author":"S Osuka","year":"2018","unstructured":"S. Osuka, N. Nakanishi, T. Murase, T. Nakamura, M. Goto, A. Iwase, F. Kikkawa, Animal models of polycystic ovary syndrome: a review of hormone-induced rodent models focused on hypothalamus-pituitary-ovary axis and neuropeptides. Reprod. Med. Biol. 18, 151\u2013160 (2018)","journal-title":"Reprod. Med. Biol."},{"key":"3404_CR9","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1095\/biolreprod.107.063974","volume":"78","author":"R Sotomayor-Z\u00e1rate","year":"2008","unstructured":"R. Sotomayor-Z\u00e1rate, M. Dorfman, A. Paredes, H.E. Lara, Neonatal exposure to estradiol valerate programs ovarian sympathetic innervation and follicular development in the adult rat. Biol. Reprod. 78, 673\u2013680 (2008)","journal-title":"Biol. Reprod."},{"key":"3404_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-019-0539-y","volume":"17","author":"B Venegas","year":"2019","unstructured":"B. Venegas, L.Y. De Le\u00f3n Gordillo, G. Rosas, J.A. Espinoza, C. Mor\u00e1n, R. Dom\u00ednguez, L. Morales-Ledesma, In rats with estradiol valerate-induced polycystic ovary syndrome, the acute blockade of ovarian \u03b2-adrenoreceptors improve ovulation. Reprod. Biol. Endocrinol. 17, 95 (2019)","journal-title":"Reprod. Biol. Endocrinol."},{"key":"3404_CR11","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/cen.12003","volume":"77","author":"A Lansdown","year":"2012","unstructured":"A. Lansdown, D.A. Rees, The sympathetic nervous system in polycystic ovary syndrome: a novel therapeutic target? Clin. Endocrinol. 77, 791\u2013801 (2012)","journal-title":"Clin. Endocrinol."},{"key":"3404_CR12","doi-asserted-by":"publisher","first-page":"E576","DOI":"10.1152\/ajpendo.00725.2007","volume":"294","author":"YB Sverrisd\u00f3ttir","year":"2008","unstructured":"Y.B. Sverrisd\u00f3ttir, T. Mogren, J. Kataoka, P.O. Janson, E. Stener-Victorin, Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth? Am. J. Physiol. Endocrinol. Metab. 294, E576\u2013E581 (2008)","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"3404_CR13","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/j.1542-474X.2006.00122.x","volume":"11","author":"A Yildirir","year":"2006","unstructured":"A. Yildirir, F. Aybar, G. Kabakci, H. Yarali, A. Oto, Heart rate variability in young women with polycystic ovary syndrome. Ann. Noninvasive Electrocardiol. 11, 306\u2013312 (2006)","journal-title":"Ann. Noninvasive Electrocardiol."},{"key":"3404_CR14","first-page":"e12510","volume":"97","author":"HR Ji","year":"2018","unstructured":"H.R. Ji, H.L. Woo, Y.J. Park, D.S. Hwang, J.M. Lee, C.H. Lee, J.B. Jang, K.S. Park, Characteristics of heart rate variability in women with polycystic ovary syndrome: a retrospective cross-sectional study. Medicines 97, e12510 (2018)","journal-title":"Medicines"},{"key":"3404_CR15","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/0002-9378(83)90324-1","volume":"145","author":"RA Lobo","year":"1983","unstructured":"R.A. Lobo, L.R. Granger, W.L. Paul, U. Goebelsmann, D.R. Mishell Jr., Psychological stress and increases in urinary norepinephrine metabolites, platelet serotonin, and adrenal androgens in women with polycystic ovary syndrome. Am. J. Obstet. Gynecol. 145, 496\u2013503 (1983)","journal-title":"Am. J. Obstet. Gynecol."},{"key":"3404_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1046\/j.1365-2265.1998.00511.x","volume":"49","author":"C Garcia-Rudaz","year":"1998","unstructured":"C. Garcia-Rudaz, I. Armando, G. Levin, M.E. Escobar, M. Barontini, Peripheral catecholamine alterations in adolescents with polycystic ovary syndrome. Clin. Endocrinol. 49, 221\u2013228 (1998)","journal-title":"Clin. Endocrinol."},{"key":"3404_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1447-0756.1990.tb00216.x","volume":"16","author":"K Yoshino","year":"1990","unstructured":"K. Yoshino, K. Takahashi, A. Nishigaki, Y. Eda, M. Kitao, Plasma catecholamine metabolites and polycystic ovary syndrome. Asia Ocean. J. Obstet. Gynaecol. 16, 57\u201362 (1990)","journal-title":"Asia Ocean. J. Obstet. Gynaecol."},{"key":"3404_CR18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0022-510X(95)00007-O","volume":"130","author":"R Levi-Montalcini","year":"1995","unstructured":"R. Levi-Montalcini, R. Dal Toso, F. della Valle, S.D. Skaper, A. Leon, Update of the NGF saga. J. Neurol. Sci. 130, 119\u2013127 (1995)","journal-title":"J. Neurol. Sci."},{"key":"3404_CR19","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1172\/JCI24066","volume":"115","author":"J Xu","year":"2005","unstructured":"J. Xu, G. Li, P. Wang, H. Velazquez, X. Yao, Y. Li, Y. Wu, A. Peixoto, S. Crowley, G.V. Desir, Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. J. Clin. Investig. 115, 1275\u20131280 (2005)","journal-title":"J. Clin. Investig."},{"key":"3404_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","volume":"106","author":"D Lizneva","year":"2016","unstructured":"D. Lizneva, L. Suturina, W. Walker, S. Brakta, L. Gavrilova-Jordan, R. Azziz, Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil. Steril. 106, 6\u201315 (2016)","journal-title":"Fertil. Steril."},{"key":"3404_CR21","first-page":"5","volume":"49","author":"R Robeva","year":"2022","unstructured":"R. Robeva, N. Arnaudova, G. Kirilov, A. Elenkova, S. Zacharieva, Metanephrine and normetanephrine urine excretion in patients with PCOS. Acta Med. Bulg. 49, 5\u201310 (2022)","journal-title":"Acta Med. Bulg."},{"key":"3404_CR22","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1093\/humrep\/deu242","volume":"29","author":"D Dewailly","year":"2014","unstructured":"D. Dewailly, M.\u0160. Alebi\u0107, A. Duhamel, N. Stojanovi\u0107, Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles. Hum. Reprod. 29, 2536\u20132543 (2014)","journal-title":"Hum. Reprod."},{"key":"3404_CR23","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.1210\/jc.2019-00065","volume":"104","author":"AJ Lansdown","year":"2019","unstructured":"A.J. Lansdown, E.A.H. Warnert, Y. Sverrisd\u00f3ttir, R.G. Wise, D.A. Rees, Regional cerebral activation accompanies sympathoexcitation in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 104, 3614\u20133623 (2019)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3404_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0165-1838(94)90127-9","volume":"50","author":"G Eisenhofer","year":"1994","unstructured":"G. Eisenhofer, W. Pecorella, K. Pacak, D. Hooper, I.J. Kopin, D.S. Goldstein, The neuronal and extraneuronal origins of plasma 3-methoxy-4-hydroxyphenylglycol in rats. J. Auton. Nerv. Syst. 50, 93\u2013107 (1994)","journal-title":"J. Auton. Nerv. Syst."},{"key":"3404_CR25","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00404-011-1947-1","volume":"284","author":"X Shi","year":"2011","unstructured":"X. Shi, L. Zhang, S. Fu, N. Li, Co-involvement of psychological and neurological abnormalities in infertility with polycystic ovarian syndrome. Arch. Gynecol. Obstet. 284, 773\u2013778 (2011)","journal-title":"Arch. Gynecol. Obstet."},{"key":"3404_CR26","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1124\/pr.56.3.1","volume":"56","author":"G Eisenhofer","year":"2004","unstructured":"G. Eisenhofer, I.J. Kopin, D.S. Goldstein, Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol. Rev. 56, 331\u2013349 (2004)","journal-title":"Pharmacol. Rev."},{"key":"3404_CR27","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1210\/en.2011-1769","volume":"153","author":"S Saller","year":"2012","unstructured":"S. Saller, J. Merz-Lange, S. Raffael, S. Hecht, R. Pavlik, C. Thaler, D. Berg, U. Berg, L. Kunz, A. Mayerhofer, Norepinephrine, active norepinephrine transporter, and norepinephrine-metabolism are involved in the generation of reactive oxygen species in human ovarian granulosa cells. Endocrinology 153, 1472\u20131483 (2012)","journal-title":"Endocrinology"},{"key":"3404_CR28","doi-asserted-by":"publisher","first-page":"4988","DOI":"10.1210\/en.2007-1661","volume":"149","author":"M Greiner","year":"2008","unstructured":"M. Greiner, A. Paredes, V. Rey-Ares, S. Saller, A. Mayerhofer, H.E. Lara, Catecholamine uptake, storage, and regulated release by ovarian granulosa cells. Endocrinology 149, 4988\u20134996 (2008)","journal-title":"Endocrinology"},{"key":"3404_CR29","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/S0015-0282(01)01805-2","volume":"75","author":"U Heider","year":"2001","unstructured":"U. Heider, I. Pedal, K. Spanel-Borowski, Increase in nerve fibers and loss of mast cells in polycystic and postmenopausal ovaries. Fertil. Steril. 75, 1141\u20131147 (2001)","journal-title":"Fertil. Steril."},{"key":"3404_CR30","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1385\/ENDO:28:3:319","volume":"28","author":"M Greiner","year":"2005","unstructured":"M. Greiner, A. Paredes, V. Araya, H.E. Lara, Role of stress and sympathetic innervation in the development of polycystic ovary syndrome. Endocrine 28, 319\u2013324 (2005)","journal-title":"Endocrine"},{"key":"3404_CR31","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1210\/endo-116-4-1645","volume":"116","author":"CA Dyer","year":"1985","unstructured":"C.A. Dyer, G.F. Erickson, Norepinephrine amplifies human chorionic gonadotropin-stimulated androgen biosynthesis by ovarian theca-interstitial cells. Endocrinology 116, 1645\u20131652 (1985)","journal-title":"Endocrinology"},{"key":"3404_CR32","first-page":"51","volume":"9","author":"F Zangeneh","year":"2015","unstructured":"F. Zangeneh, R. Salman Yazdi, M.M. Naghizadeh, N. Abedinia, Effect of Ramadan fasting on stress neurohormones in women with polycystic ovary syndrome. J. Fam. Reprod. Health 9, 51\u201357 (2015)","journal-title":"J. Fam. Reprod. Health"},{"key":"3404_CR33","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.3389\/fphys.2018.01486","volume":"9","author":"S Shorakae","year":"2018","unstructured":"S. Shorakae, E.A. Lambert, E. Jona, C. Ika Sari, B. de Courten, J.B. Dixon, G.W. Lambert, H.J. Teede, Effect of central sympathoinhibition with moxonidine on sympathetic nervous activity in polycystic ovary syndrome-a randomized controlled trial. Front. Physiol. 9, 1486 (2018)","journal-title":"Front. Physiol."},{"key":"3404_CR34","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0006-8993(77)90765-X","volume":"133","author":"U Otten","year":"1977","unstructured":"U. Otten, M. Schwab, C. Gagnon, H. Thoenen, Selective induction of tyrosine hydroxylase and dopamine beta-hydroxylase by nerve growth factor: comparison between adrenal medulla and sympathetic ganglia of adult and newborn rats. Brain Res. 133, 291\u2013303 (1977)","journal-title":"Brain Res"},{"issue":"13","key":"3404_CR35","doi-asserted-by":"publisher","first-page":"6039","DOI":"10.1016\/S0021-9258(17)38490-9","volume":"261","author":"Y Furukawa","year":"1986","unstructured":"Y. Furukawa, S. Furukawa, E. Satoyoshi, K. Hayashi, Catecholamines induce an increase in nerve growth factor content in the medium of mouse L-M cells. J. Biol. Chem. 261(13), 6039\u20136047 (1986)","journal-title":"J. Biol. Chem."},{"key":"3404_CR36","doi-asserted-by":"publisher","first-page":"4494","DOI":"10.1210\/en.2014-1368","volume":"155","author":"JL Wilson","year":"2014","unstructured":"J.L. Wilson, W. Chen, G.A. Dissen, S.R. Ojeda, M.A. Cowley, C. Garcia-Rudaz, P.J. Enriori, Excess of nerve growth factor in the ovary causes a polycystic ovary-like syndrome in mice, which closely resembles both reproductive and metabolic aspects of the human syndrome. Endocrinology 155, 4494\u20134506 (2014)","journal-title":"Endocrinology"},{"key":"3404_CR37","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1210\/endo.141.3.7396","volume":"141","author":"GA Dissen","year":"2000","unstructured":"G.A. Dissen, H.E. Lara, V. Leyton, A. Paredes, D.F. Hill, M.E. Costa, A. Martinez-Serrano, S.R. Ojeda, Intraovarian excess of nerve growth factor increases androgen secretion and disrupts estrous cyclicity in the rat. Endocrinology 141, 1073\u20131082 (2000)","journal-title":"Endocrinology"},{"key":"3404_CR38","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1210\/endo.141.3.7395","volume":"141","author":"HE Lara","year":"2000","unstructured":"H.E. Lara, G.A. Dissen, V. Leyton, A. Paredes, H. Fuenzalida, J.L. Fiedler, S.R. Ojeda, An increased intraovarian synthesis of nerve growth factor and its low affinity receptor is a principal component of steroid-induced polycystic ovary in the rat. Endocrinology 141, 1059\u20131072 (2000)","journal-title":"Endocrinology"},{"key":"3404_CR39","doi-asserted-by":"publisher","first-page":"636600","DOI":"10.3389\/fendo.2021.636600","volume":"12","author":"A Benitez","year":"2021","unstructured":"A. Benitez, R. Riquelme, M. Del Campo, C. Araya, H.E. Lara, Nerve growth factor: a dual activator of noradrenergic and cholinergic systems of the rat ovary. Front. Endocrinol. 12, 636600 (2021)","journal-title":"Front. Endocrinol."},{"key":"3404_CR40","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.yfrne.2014.04.002","volume":"35","author":"AV Roland","year":"2014","unstructured":"A.V. Roland, S.M. Moenter, Reproductive neuroendocrine dysfunction in polycystic ovary syndrome: insight from animal models. Front. Neuroendocrinol. 35, 494\u2013511 (2014)","journal-title":"Front. Neuroendocrinol."},{"key":"3404_CR41","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1210\/en.2008-1575","volume":"150","author":"GA Dissen","year":"2009","unstructured":"G.A. Dissen, C. Garcia-Rudaz, A. Paredes, C. Mayer, A. Mayerhofer, S.R. Ojeda, Excessive ovarian production of nerve growth factor facilitates development of cystic ovarian morphology in mice and is a feature of polycystic ovarian syndrome in humans. Endocrinology 150, 2906\u20132914 (2009)","journal-title":"Endocrinology"},{"key":"3404_CR42","first-page":"110","volume":"68","author":"FA Gulino","year":"2016","unstructured":"F.A. Gulino, E. Giuffrida, E. Leonardi, I. Marilli, M.A. Palumbo, Intrafollicular nerve growth factor concentration in patients with polycystic ovary syndrome: a case-control study. Minerva Ginecol. 68, 110\u2013116 (2016)","journal-title":"Minerva Ginecol."},{"key":"3404_CR43","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.fertnstert.2007.08.085","volume":"90","author":"E Buyuk","year":"2008","unstructured":"E. Buyuk, D.B. Seifer, Follicular-fluid neurotrophin levels in women undergoing assisted reproductive technology for different etiologies of infertility. Fertil. Steril. 90, 1611\u20131615 (2008)","journal-title":"Fertil. Steril."},{"key":"3404_CR44","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/09513590.2016.1250152","volume":"33","author":"FZ Zangeneh","year":"2017","unstructured":"F.Z. Zangeneh, M.M. Naghizadeh, M. Bagheri, M. Jafarabadi, Are CRH & NGF as psychoneuroimmune regulators in women with polycystic ovary syndrome?. Gynecol. Endocrinol. 33, 227\u2013233 (2017)","journal-title":"Gynecol. Endocrinol."},{"key":"3404_CR45","first-page":"925","volume":"11","author":"YW Chen","year":"2015","unstructured":"Y.W. Chen, P.Y. Lin, K.Y. Tu, Y.S. Cheng, C.K. Wu, P.T. Tseng, Significantly lower nerve growth factor levels in patients with major depressive disorder than in healthy subjects: a meta-analysis and systematic review. Neuropsychiatr. Dis. Treat. 11, 925\u2013933 (2015)","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"3404_CR46","doi-asserted-by":"publisher","first-page":"41","DOI":"10.31887\/DCNS.2018.20.1\/klrooney","volume":"20","author":"KL Rooney","year":"2018","unstructured":"K.L. Rooney, A.D. Domar, The relationship between stress and infertility. Dialogues Clin. Neurosci. 20, 41\u201347 (2018)","journal-title":"Dialogues Clin. Neurosci."},{"issue":"16","key":"3404_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-018-0402-6","volume":"31","author":"RA Carrasco","year":"2018","unstructured":"R.A. Carrasco, J. Singh, G.P. Adams, The relationship between gonadotropin releasing hormone and ovulation inducing factor\/nerve growth factor receptors in the hypothalamus of the llama. Reprod. Biol. Endocrinol. 31(16), 83 (2018)","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"13","key":"3404_CR48","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3390\/ani13061004","volume":"9","author":"G Gajardo","year":"2023","unstructured":"G. Gajardo, L. Paiva, C. Ulloa-Leal, X. Valderrama, G. L\u00f3pez, A. Carrasco, A.I. Hidalgo, M.E. Silva, P.I. Palma, M.H. Ratto, Administration of beta-nerve growth factor during the preovulatory stage improves endocrine and luteal function in dairy heifers. Animals 9(13), 1004 (2023)","journal-title":"Animals"},{"key":"3404_CR49","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1073\/pnas.93.9.4240","volume":"93","author":"C Missale","year":"1996","unstructured":"C. Missale, F. Boroni, S. Sigala, A. Buriani, M. Fabris, A. Leon, R. Dal Toso, P. Spano, Nerve growth factor in the anterior pituitary: localization in mammotroph cells and cosecretion with prolactin by a dopamine-regulated mechanism. Proc. Natl Acad. Sci. USA. 93, 4240\u20134245 (1996)","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"3404_CR50","doi-asserted-by":"publisher","first-page":"E331","DOI":"10.1152\/ajpendo.00076.2004","volume":"287","author":"MR Peeraully","year":"2004","unstructured":"M.R. Peeraully, J.R. Jenkins, P. Trayhurn, NGF gene expression and secretion in white adipose tissue: regulation in 3T3-L1 adipocytes by hormones and inflammatory cytokines. Am. J. Physiol. Endocrinol. Metab. 287, E331\u2013E339 (2004)","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"3404_CR51","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S0188-4409(00)00059-X","volume":"31","author":"I Hern\u00e1ndez","year":"2000","unstructured":"I. Hern\u00e1ndez, A. Parra, I. M\u00e9ndez, V. Cabrera, M.C. Cravioto, M. Mercado, V. D\u00edaz-S\u00e1nchez, F. Larrea, Hypothalamic dopaminergic tone and prolactin bioactivity in women with polycystic ovary syndrome. Arch. Med. Res. 31, 216\u2013222 (2000)","journal-title":"Arch. Med. Res."},{"key":"3404_CR52","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000181867","volume":"35","author":"A Velardo","year":"1991","unstructured":"A. Velardo, M. Pantaleoni, C. Zironi, G. Zizzo, P. Marrama, Evidence of altered dopaminergic modulation of prolactin and thyrotropin secretion in patients with polycystic ovary syndrome. Horm. Res. 35, 4\u20137 (1991)","journal-title":"Horm. Res."},{"key":"3404_CR53","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.3390\/diagnostics12122924","volume":"12","author":"M Saei Ghare Naz","year":"2022","unstructured":"M. Saei Ghare Naz, M. Mousavi, F. Mahboobifard, A. Niknam, F. Ramezani Tehrani, A meta-analysis of observational studies on prolactin levels in women with polycystic ovary syndrome. Diagnostics 12, 2924 (2022)","journal-title":"Diagnostics"},{"key":"3404_CR54","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1530\/EJE-06-0716","volume":"157","author":"M Bull\u00f3","year":"2007","unstructured":"M. Bull\u00f3, M.R. Peeraully, P. Trayhurn, J. Folch, J. Salas-Salvad\u00f3, Circulating nerve growth factor levels in relation to obesity and the metabolic syndrome in women. Eur. J. Endocrinol. 157, 303\u2013310 (2007)","journal-title":"Eur. J. Endocrinol."},{"key":"3404_CR55","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1076\/apab.109.4.357.4249","volume":"109","author":"GN Chaldakov","year":"2001","unstructured":"G.N. Chaldakov, M. Fiore, I.S. Stankulov, M. Hristova, A. Antonelli, L. Manni, P.I. Ghenev, F. Angelucci, L. Aloe, NGF, BDNF, leptin, and mast cells in human coronary atherosclerosis and metabolic syndrome. Arch. Physiol. Biochem. 109, 357\u2013360 (2001)","journal-title":"Arch. Physiol. Biochem."},{"key":"3404_CR56","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.3390\/ijms24031957","volume":"24","author":"J Samario-Rom\u00e1n","year":"2023","unstructured":"J. Samario-Rom\u00e1n, C. Larqu\u00e9, P. P\u00e1nico, R.I. Ortiz-Huidobro, M. Velasco, R. Escalona, M. Hiriart, NGF and its role in immunoendocrine communication during metabolic syndrome. Int. J. Mol. Sci. 24, 1957 (2023)","journal-title":"Int. J. Mol. Sci."},{"key":"3404_CR57","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1113\/jphysiol.2011.221036","volume":"590","author":"MM Smith","year":"2012","unstructured":"M.M. Smith, C.T. Minson, Obesity and adipokines: effects on sympathetic overactivity. J. Physiol. 590, 1787\u20131801 (2012)","journal-title":"J. Physiol."},{"key":"3404_CR58","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.bbapap.2015.04.010","volume":"1864","author":"GR Moran","year":"2016","unstructured":"G.R. Moran, The catalytic function of renalase: a decade of phantoms. Biochim. Biophys. Acta 1864, 177\u2013186 (2016)","journal-title":"Biochim. Biophys. Acta"},{"key":"3404_CR59","doi-asserted-by":"publisher","first-page":"334","DOI":"10.5603\/EP.a2020.0044","volume":"71","author":"J Czubili\u0144ska-\u0141ada","year":"2020","unstructured":"J. Czubili\u0144ska-\u0141ada, A. Gliwi\u0144ska, A. Bade\u0144ski, M. Szczepa\u0144ska, Associations between renalase concentration and the occurrence of selected diseases. Endokrynol. Pol. 71, 334\u2013342 (2020)","journal-title":"Endokrynol. Pol."},{"key":"3404_CR60","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1038\/s41440-022-00986-1","volume":"45","author":"A Vijayakumar","year":"2022","unstructured":"A. Vijayakumar, N.R. Mahapatra, Renalase: a novel regulator of cardiometabolic and renal diseases. Hypertens. Res. 45, 1582\u20131598 (2022)","journal-title":"Hypertens. Res."},{"key":"3404_CR61","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/ki.2010.488","volume":"79","author":"Y Wu","year":"2011","unstructured":"Y. Wu, J. Xu, H. Velazquez, P. Wang, G. Li, D. Liu, B. Sampaio-Maia, J. Quelhas-Santos, K. Russell, R. Russell, R.A. Flavell, M. Pestana, F. Giordano, G.V. Desir, Renalase deficiency aggravates ischemic myocardial damage. Kidney Int. 79, 853\u2013860 (2011)","journal-title":"Kidney Int."},{"key":"3404_CR62","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.2147\/CIA.S106109","volume":"11","author":"E Zbroch","year":"2016","unstructured":"E. Zbroch, D. Musialowska, E. Koc-Zorawska, J. Malyszko, Age influence on renalase and catecholamines concentration in hypertensive patients, including maintained dialysis. Clin. Interv. Aging 11, 1545\u20131550 (2016)","journal-title":"Clin. Interv. Aging"},{"key":"3404_CR63","doi-asserted-by":"publisher","first-page":"9159","DOI":"10.1002\/jcb.28191","volume":"120","author":"H Akbari","year":"2019","unstructured":"H. Akbari, G. Asadikaram, S. Vakili, M. Masoumi, Atorvastatin and losartan may upregulate renalase activity in hypertension but not coronary artery diseases: the role of gene polymorphism. J. Cell Biochem. 120, 9159\u20139171 (2019)","journal-title":"J. Cell Biochem."},{"key":"3404_CR64","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1080\/03630242.2021.1994512","volume":"61","author":"X Li","year":"2021","unstructured":"X. Li, Q. Huang, J. Xu, Renalase gene polymorphisms and plasma levels are associated with preeclampsia: a hospital-based study in the Chinese cohort. Women Health 61, 957\u2013967 (2021)","journal-title":"Women Health"},{"key":"3404_CR65","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1007\/s00246-018-1891-y","volume":"39","author":"M Lemiesz","year":"2018","unstructured":"M. Lemiesz, E. Tenderenda-Banasiuk, D. Sosnowska, K. Taranta-Janusz, A. Wasilewska, Serum renalase levels in adolescents with primary hypertension. Pediatr. Cardiol. 39, 1258\u20131264 (2018)","journal-title":"Pediatr. Cardiol."},{"key":"3404_CR66","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1007\/s11033-012-2476-0","volume":"40","author":"M Zhou","year":"2013","unstructured":"M. Zhou, T. Liang, Y. Wang, D. Jin, J. Wang, L. Jia, S. Zhang, Expression and tissue localization of renalase, a novel soluble FAD-dependent protein, in reproductive\/steroidogenic systems. Mol. Biol. Rep. 40, 3987\u20133994 (2013)","journal-title":"Mol. Biol. Rep."},{"key":"3404_CR67","doi-asserted-by":"publisher","first-page":"e13434","DOI":"10.1111\/and.13434","volume":"51","author":"SS Fatima","year":"2019","unstructured":"S.S. Fatima, R. Rehman, R.S. Martins, F. Alam, M. Ashraf, Single nucleotide polymorphisms in Renalase and KCNQ1 genes and female infertility: a cross-sectional study in Pakistan. Andrologia 51, e13434 (2019)","journal-title":"Andrologia"},{"key":"3404_CR68","doi-asserted-by":"publisher","DOI":"10.1177\/2054358117698669","volume":"4","author":"CP Kovesdy","year":"2017","unstructured":"C.P. Kovesdy, S.L. Furth, C. Zoccali; World Kidney Day Steering Committee, Obesity and kidney disease: hidden consequences of the epidemic. Can. J. Kidney Health Dis. 4, 2054358117698669 (2017)","journal-title":"Can. J. Kidney Health Dis."},{"key":"3404_CR69","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s43032-022-01100-z","volume":"30","author":"J Finsterer","year":"2023","unstructured":"J. Finsterer, Mitochondrial dysfunction in polycystic ovary syndrome. Reprod. Sci. 30, 1435\u20131442 (2023)","journal-title":"Reprod. Sci."},{"key":"3404_CR70","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1080\/09513590.2017.1393062","volume":"34","author":"S Patlolla","year":"2018","unstructured":"S. Patlolla, S. Vaikkakara, A. Sachan, A. Venkatanarasu, B. Bachimanchi, A. Bitla, S. Settipalli, S. Pathiputturu, R.N. Sugali, S. Chiri, Heterogenous origins of hyperandrogenism in the polycystic ovary syndrome in relation to body mass index and insulin resistance. Gynecol. Endocrinol. 34, 238\u2013242 (2018)","journal-title":"Gynecol. Endocrinol."},{"key":"3404_CR71","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.euroneuro.2021.10.864","volume":"55","author":"M Manchia","year":"2022","unstructured":"M. Manchia, A.W. Gathier, H. Yapici-Eser, M.V. Schmidt, D. de Quervain, T. van Amelsvoort, J.I. Bisson, J.F. Cryan, O.D. Howes, L. Pinto, N.J. van der Wee, K. Domschke, I. Branchi, C.H. Vinkers, The impact of the prolonged COVID-19 pandemic on stress resilience and mental health: a critical review across waves. Eur. Neuropsychopharmacol. 55, 22\u201383 (2022)","journal-title":"Eur. Neuropsychopharmacol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03404-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-023-03404-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03404-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T16:32:28Z","timestamp":1744216348000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-023-03404-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,29]]},"references-count":71,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["3404"],"URL":"https:\/\/doi.org\/10.1007\/s12020-023-03404-9","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,29]]},"assertion":[{"value":"1 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Medical University\u2014Sofia (26.05.2021\/Protocol \u211616).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}